Brief: Salarius Pharmaceuticals says FDA Placing Clinical Trial Evaluating Seclidemstat (Sp-2577) In Combination With Azacitidine On Partial Clinical Hold

Decoy Therapeutics

11/07/2024 13:25

July 11 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS - FDA PLACING CLINICAL TRIAL
EVALUATING
SECLIDEMSTAT (SP-2577) IN COMBINATION WITH AZACITIDINE ON
PARTIAL CLINICAL HOLD
    * SALARIUS PHARMACEUTICALS: INTENDS TO SUPPORT RESEARCHERS
AT
MDACC TO ANALYZE AVAILABLE DATA & RESPOND TO QUESTIONS SUBMITTED
BY FDA - SEC FILING
    * SALARIUS PHARMACEUTICALS INC: PATIENT IN TRIAL EXPERIENCED
A
SERIOUS AND UNEXPECTED GRADE 4 ADVERSE EVENT

Source text for Eikon:  ID:n0001615219-24-000055 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))